OptiNose, Inc.
OPTN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $78 | $71 | $76 | $75 |
| % Growth | 10.2% | -6.9% | 2.2% | – |
| Cost of Goods Sold | $7 | $9 | $9 | $9 |
| Gross Profit | $71 | $62 | $67 | $66 |
| % Margin | 90.8% | 87.8% | 87.9% | 87.7% |
| R&D Expenses | $4 | $5 | $15 | $25 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $83 | $80 | $108 | $107 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $87 | $85 | $123 | $132 |
| Operating Income | -$16 | -$23 | -$56 | -$66 |
| % Margin | -20.9% | -32% | -73.3% | -89% |
| Other Income/Exp. Net | -$5 | -$13 | -$19 | -$16 |
| Pre-Tax Income | -$22 | -$35 | -$75 | -$82 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22 | -$35 | -$75 | -$82 |
| % Margin | -27.5% | -50% | -98.1% | -109.4% |
| EPS | -2.12 | -0.32 | -13.05 | -1.44 |
| % Growth | -562.5% | 97.5% | -806.3% | – |
| EPS Diluted | -2.12 | -0.32 | -13.05 | -1.44 |
| Weighted Avg Shares Out | 10 | 112 | 6 | 57 |
| Weighted Avg Shares Out Dil | 10 | 112 | 6 | 57 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $1 | $0 |
| Interest Expense | $20 | $20 | $17 | $16 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | -$1 | -$16 | -$57 | -$66 |
| % Margin | -1.5% | -21.9% | -75.3% | -88% |